$172 Million is the total value of Prism Advisors, Inc.'s 54 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 23.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Sell | INVESCO QQQ TRunit ser 1 | $23,311,000 | -12.5% | 134,042 | -11.6% | 13.56% | -4.3% |
| SPY | Sell | SPDR S&P 500 ETF TRtr unit | $11,404,000 | -49.1% | 41,469 | -49.0% | 6.63% | -44.3% |
| EEM | Sell | ISHARES TRmsci emg mkt etf | $6,427,000 | -60.1% | 160,269 | -56.8% | 3.74% | -56.4% |
| FF | Sell | FUTUREFUEL CORPORATION | $2,768,000 | -6.7% | 171,400 | -16.7% | 1.61% | +2.0% |
| TGNA | Sell | TEGNA INC | $2,666,000 | -2.4% | 222,328 | -5.2% | 1.55% | +6.7% |
| VIAB | Sell | VIACOM INC NEWcl b | $2,643,000 | +3.6% | 80,104 | -5.8% | 1.54% | +13.2% |
| KSS | Sell | KOHLS CORP | $2,629,000 | -6.7% | 36,006 | -8.8% | 1.53% | +2.0% |
| CVS | Sell | CVS HEALTH CORP | $2,563,000 | -0.5% | 35,191 | -9.2% | 1.49% | +8.8% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $2,492,000 | -21.9% | 117,399 | -11.2% | 1.45% | -14.6% |
| R | Sell | RYDER SYS INC | $2,240,000 | -16.3% | 34,749 | -4.9% | 1.30% | -8.4% |
| HPQ | Sell | HP INC | $1,313,000 | -4.9% | 54,454 | -9.2% | 0.76% | +4.1% |
| GBDC | Sell | GOLUB CAP BDC INC | $1,257,000 | -5.4% | 69,772 | -2.1% | 0.73% | +3.4% |
| TCRD | Sell | THL CR INC | $1,247,000 | -5.0% | 160,732 | -0.4% | 0.72% | +3.7% |
| ATGE | Sell | ADTALEM GLOBAL ED INC | $1,174,000 | -56.4% | 24,661 | -53.6% | 0.68% | -52.3% |
| AAPL | Sell | APPLE INC | $720,000 | -31.4% | 3,261 | -41.6% | 0.42% | -25.0% |
| VTV | Sell | VANGUARD INDEX FDSvalue etf | $377,000 | -4.1% | 3,551 | -5.0% | 0.22% | +4.8% |
| XOM | Sell | EXXON MOBIL CORP | $313,000 | -28.0% | 3,853 | -27.1% | 0.18% | -21.2% |
| JNJ | Sell | JOHNSON & JOHNSON | $248,000 | -9.5% | 1,788 | -18.1% | 0.14% | -1.4% |
| DSI | Sell | ISHARES TRmsci kld400 soc | $223,000 | -8.6% | 2,231 | -6.1% | 0.13% | 0.0% |
| ANTM | Sell | ANTHEM INC | $217,000 | +2.4% | 786 | -10.4% | 0.13% | +11.5% |
| ZIOP | Exit | ZIOPHARM ONCOLOGY INC | $0 | – | -17,331 | -100.0% | -0.03% | – |
| CX | Exit | CEMEX SAB DE CVspon adr new | $0 | – | -10,042 | -100.0% | -0.04% | – |
| IBB | Exit | ISHARES TRnasdaq biotech | $0 | – | -1,762 | -100.0% | -0.11% | – |
| XBI | Exit | SPDR SERIES TRUSTs&p biotech | $0 | – | -3,728 | -100.0% | -0.20% | – |
| IBMG | Exit | ISHARES TRibonds sep18 etf | $0 | – | -81,277 | -100.0% | -1.10% | – |
| ARII | Exit | AMERICAN RAILCAR INDS INC | $0 | – | -67,116 | -100.0% | -1.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-10-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 24 | Q3 2023 | 9.8% |
| SPDR S&P 500 ETF TRUST | 24 | Q3 2023 | 14.6% |
| ISHARES TR | 24 | Q3 2023 | 8.5% |
| ISHARES TR | 24 | Q3 2023 | 9.8% |
| VANGUARD VALUE ETF | 24 | Q3 2023 | 5.2% |
| ISHARES TR | 24 | Q3 2023 | 1.2% |
| ISHARES TR | 24 | Q3 2023 | 0.4% |
| APPLE INC COM | 24 | Q3 2023 | 0.6% |
| ISHARES TR | 24 | Q3 2023 | 0.7% |
| ISHARES TR | 24 | Q3 2023 | 0.4% |
View Prism Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-05 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-12 |
| 13F-HR | 2022-07-11 |
| 13F-HR | 2022-04-25 |
| 13F-HR | 2022-02-11 |
View Prism Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.